Resistance to type 2 diabetes mellitus: A matter of hormesis?

Nature Reviews Endocrinology

Volumn 8, Issue 3, 2012, Pages 183-192

  Kolb, Hubert ^a   Eizirik, Décio L ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ANIMAL; BLOOD; DISEASE RESISTANCE; GLUCOSE BLOOD LEVEL; HORMESIS; HUMAN; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSIOLOGY; REVIEW;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DISEASE RESISTANCE; HORMESIS; HUMANS; INSULIN;

EID: 84862742993     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2011.158     Document Type: Article

References (131)

1. Kolb, H. and Mandrup-Poulsen, T The global diabetes epidemic as a consequence of lifestyle- induced low-grade inflammation. Diabetologia 53, 10-20 (2010).
2. Bonora, E. et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck study. Diabetes 47, 1643-1649 (1998).
3. Ferrannini, E. et al. European Group for the Study of Insulin Resistance (EGIR). J. Clin. Invest. 100, 1166-1173 (1997).
4. Primeau, V et al. Characterizing the profile of obese patients who are metabolically healthy. Int. J. Obes. (Lond.) 35, 971-981 (2011).
5. Velho, S., Paccaud, F., Waeber, G., Vollenweider, P and Marques-Vidal, P. Metabolically healthy obesity: different prevalences using different criteria. Eur. J. Clin. Nutr. 64, 1043-1051 (2010).
6. Kloting, N. et al. Insulin-sensitive obesity. Am. J. Physiol. Endocrinol. Metab. 299, E506-E515 (2010).
7. Calori, G. et al. Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona study. Diabetes Care 34, 210-215 (2011).
8. Cnop, M. et al. Mechanisms of pancreatic 3-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54 (Suppl. 2), 97-107 (2005).
9. Matveyenko, A. V. and Butler, P C. Relationship between 3-cell mass and diabetes onset. Diabetes. Obes. Metab. 10 (Suppl. 4), 23-31 (2008).
10. Donath, M. Y and Shoelson, S. E. Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 11, 98-107 (2011).
11. Li, G. et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 371, 1783-1789 (2008).
12. Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 374, 1677-1686 (2009)
13. Calabrese, E. J. et al. Biological stress response terminology: integrating the concepts of adaptive response and preconditioning stress within a hormetic dose-response framework. Toxicol. Appl. Pharmacol. 222, 122-128 (2007).
14. Mohanty, P et al. Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J. Clin. Endocrinol. Metab. 85, 2970-2973 (2000).
15. Esposito, K. et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106, 2067-2072 (2002).
16. Esposito, K. et al. Meal modulation of circulating interleukin 18 and adiponectin concentrations in healthy subjects and in patients with type 2 diabetes mellitus. Am. J. Clin. Nutr. 78, 1135-1140 (2003).
17. Aljada, A. et al. Increase in intranuclear nuclear factor kB and decrease in inhibitor kB in mononuclear cells after a mixed meal: evidence for a proinflammatory effect. Am. J. Clin. Nutr. 79, 682-690 (2004).
18. van Oostrom, A. J. et al. Activation of leukocytes by postprandial lipemia in healthy volunteers. Atherosclerosis 177, 175-182 (2004).
19. Devaraj, S., Wang-Polagruto, J., Polagruto, J., Keen, C. L. and Jialal, I. High-fat, energy-dense, fast-food-style breakfast results in an increase in oxidative stress in metabolic syndrome. Metabolism 57, 867-870 (2008).
20. Dickinson, S., Hancock, D. P., Petocz, P., Ceriello, A., Brand-Miller, J. High-glycemic index carbohydrate increases nuclear factor-KB activation in mononuclear cells of young, lean healthy subjects. Am. J. Clin. Nutr. 87, 1188-1193 (2008).
21. Jin, M. S. and Lee, J. O. Structures of the Toll-like receptor family and its ligand complexes. Immunity 29, 182-191 (2008).
22. Weatherill, A. R. et al. Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through TLR4. J. Immunol. 174, 5390-5397 (2005).
23. Shi, H. et al. TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 116, 3015-3025 (2006).
24. Schaeffler, A. et al. Fatty acid-induced induction of Toll-like receptor-4/nuclear factor-KB pathway in adipocytes links nutritional signalling with innate immunity. Immunology 126, 233-245 (2009).
25. Schwartz, E. A. et al. Nutrient modification of the innate immune response: a novel mechanism by which saturated fatty acids greatly amplify monocyte inflammation. Arterioscler. Thromb. Vasc. Biol. 30, 802-808 (2010).
26. Medvedev, A. E., Sabroe, I., Hasday, J. D. and Vogel, S. N. Tolerance to microbial TLR ligands: molecular mechanisms and relevance to disease. J. Endotoxin. Res. 12, 133-150 (2006).
27. Biswas, S. K. et al. Role for MyD88-independent, TRIF pathway in lipid A/TLR4-induced endotoxin tolerance. J. Immunol. 179, 4083-4092 (2007).
28. Piao, W. et al. Endotoxin tolerance dysregulates MyD88- and Toll/IL-1R domain-containing adapter inducing IFN-p-dependent pathways and increases expression of negative regulators of TLR signaling. J. Leukoc. Biol. 86, 863-875 (2009).
29. Ray, M. et al. Inhibition of TLR4-induced IKB kinase activity by the RON receptor tyrosine kinase and its ligand, macrophage-stimulating protein. J. Immunol. 185, 7309-7316 (2010).
30. Boden, G. Obesity and free fatty acids. Endocrinol. Metab. Clin. North Am. 37, 635-646 (2008).
31. Dasu, M. R., Devaraj, S., Zhao, L., Hwang, D. H. and Jialal, I. High glucose induces Toll-like receptor expression in human monocytes: mechanism of activation. Diabetes 57, 3090-3098 (2008).
32. Gubern, C. et al. Natural antibiotics and insulin sensitivity: the role of bactericidal/permeability- increasing protein. Diabetes 55, 216-224 (2006).
33. Creely, S. J. et al. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 292, E740-E747 (2007).
34. Harte, A. L. et al. Elevated endotoxin levels in non-alcoholic fatty liver disease. J. Inflamm. (Lond.) 7, 15 (2010).
35. Dasu, M. R., Devaraj, S., Park, S. and Jialal, I. Increased Toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes Care 33, 861-868 (2010).
36. Chacón, M. R. et al. Different TNFa expression elicited by glucose in monocytes from type 2 diabetes mellitus patients. Atherosclerosis 194, 18-25 (2007).
37. Wu, H. P, Kuo, S. F., Wu, S. Y and Chuang, D. Y High interleukin-12 production from stimulated peripheral blood mononuclear cells of type 2 diabetes patients. Cytokine 51, 298-304 (2010)
38. Bala, M. et al. Type 2 diabetes and lipoprotein metabolism affect LPS-induced cytokine and chemokine release in primary human monocytes. Exp. Clin. Endocrinol. Diabetes 119, 370-376 (2011).
39. Reyna, S. M. et al. Elevated Toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects. Diabetes 57, 2595-2602 (2008).
40. van Exel, E. et al. Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes: the Leiden 85- Plus Study. Diabetes 51, 1088-1092 (2002).
41. Dasu, M. R., Jialal, I. Free fatty acids in the presence of high glucose amplify monocyte inflammation via Toll-like receptors. Am. J. Physiol. Endocrinol. Metab. 300, 145-154 (2011).
42. Kim, H. J. et al. Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo. Diabetes 53, 1060-1067 (2004).
43. Nappo, F. et al. Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals. J. Am. Coll. Cardiol. 39, 1145-1150 (2002).
44. Blackburn, P et al. Postprandial variations of plasma inflammatory markers in abdominally obese men. Obesity (Silver Spring) 14, 1747-1754 (2006).
45. Patel, C. et al. Prolonged reactive oxygen species generation and nuclear factor-KB activation after a high-fat, high-carbohydrate meal in the obese. J. Clin. Endocrinol. Metab. 92, 4476-4479 (2007).
46. Kempf, K. et al. The metabolic syndrome sensitizes leukocytes for glucose-induced immune gene expression. J. Mol. Med. 85, 389-396 (2007).
47. Gonzalez, F., Rote, N. S., Minium, J., O’leary, V. B. and Kirwan, J. P Obese reproductive-age women exhibit a proatherogenic inflammatory response during hyperglycemia. Obesity (Silver Spring) 15, 2436-2444 (2007).
48. Zacharioudaki, V. et al. Adiponectin promotes endotoxin tolerance in macrophages by inducing IRAK-M expression. J. Immunol. 182, 6444-6451 (2009).
49. Barbarroja, N. et al. The obese healthy paradox: is inflammation the answer? Biochem. J. 430, 141-149 (2010).
50. Lambert, A. J. and Brand, M. D. Reactive oxygen species production by mitochondria. Methods Mol. Biol. 554, 165-181 (2009).
51. Mari, M., Morales, A., Colell, A., Garcia-Ruiz, C. and Fernandez-Checa, J. C. Mitochondrial glutathione, a key survival antioxidant. Antioxid. Redox. Signal. 11, 2685-2700 (2009).
52. El Osta, A. et al. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J. Exp. Med. 205, 2409-2417 (2008).
53. Lambertucci, R. H. et al. Palmitate increases superoxide production through mitochondrial electron transport chain and NADPH oxidase activity in skeletal muscle cells. J. Cell Physiol. 216, 796-804 (2008).
54. Dasu, M. R., Devaraj, S. and Jialal, I. High glucose induces IL-1p expression in human monocytes: mechanistic insights. Am. J. Physiol. Endocrinol. Metab. 293, 337-346 (2007).
55. Short, K. R. et al. Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity. Diabetes 52, 1888-1896 (2003).
56. Ristow, M. et al. Antioxidants prevent health- promoting effects of physical exercise in humans. Proc. Natl Acad. Sci. USA 106, 8665-8670 (2009).
57. Gomez-Cabrera, M. C. et al. Oral administration of vitamin C decreases muscle mitochondrial biogenesis and hampers training-induced adaptations in endurance performance. Am. J. Clin. Nutr. 87, 142-149 (2008).
58. Strobel, N. A. et al. Antioxidant supplementation reduces skeletal muscle mitochondrial biogenesis. Med. Sci. Sports Exerc. 43, 1017-1024 (2011).
59. Cheng, X., Siow, R. C. and Mann, G. E. Impaired redox signaling and antioxidant gene expression in endothelial cells in diabetes: a role for mitochondria and the nuclear factor-E2-related factor 2-Kelch-like ECH-associated protein 1 defense pathway. Antioxid. Redox. Signal. 14, 469-487 (2011).
60. Yu, Z. et al. Oltipraz upregulates the nuclear factor (erythroid-derived 2)-like 2 (NRF2) antioxidant system and prevents insulin resistance and obesity induced by a high-fat diet in C57BL/6J mice. Diabetologia 54, 922-934 (2011).
61. Narkar, V. A. et al. AMPK and PPARS agonists are exercise mimetics. Cell 134, 405-415 (2008).
62. Ristow, M. and Zarse, K. How increased oxidative stress promotes longevity and metabolic health: the concept of mitochondrial hormesis (mitohormesis). Exp. Gerontol. 45, 410-418 (2010).
63. Gupte, A. A., Bomhoff, G. L., Swerdlow, R. H. and Geiger, P. C. Heat treatment improves glucose tolerance and prevents skeletal muscle insulin resistance in rats fed a high-fat diet. Diabetes 58, 567-578 (2009).
64. Pallepati, P. and Averill-Bates, D. Mild thermotolerance induced at 40 degrees C increases antioxidants and protects HeLa cells against mitochondrial apoptosis induced by hydrogen peroxide: Role of p53. Arch. Biochem. Biophys. 495, 97-111 (2010).
65. Schulz, T. J. et al. Glucose restriction extends Caenorhabditis elegans life span by inducing mitochondrial respiration and increasing oxidative stress. Cell. Metab. 6, 280-293 (2007).
66. Lee, S. J., Hwang, A. B. and Kenyon, C. Inhibition of respiration extends C. elegans life span via reactive oxygen species that increase HIF-1 activity. Curr. Biol. 20, 2131-2136 (2010).
67. Schlotterer, A. et al. C. elegans as model for the study of high glucose-mediated life span reduction. Diabetes 58, 2450-2456 (2009).
68. Kelley, D. E., He, J., Menshikova, E. V. and Ritov, V. B. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51, 2944-2950 (2002).
69. Petersen, K. F., Dufour, S., Befroy, D., Garcia, R. and Shulman, G. I. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N. Engl. J. Med. 350, 664-671 (2004).
70. Boushel, R. et al. Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia 50, 790-796 (2007).
71. Bruce, C. R., Kriketos, A. D., Cooney, G. J. and Hawley, J. A. Disassociation of muscle triglyceride content and insulin sensitivity after exercise training in patients with type 2 diabetes. Diabetologia 47, 23-30 (2004).
72. Hatunic, M., Burns, N., Finucane, F., Mannion, C. and Nolan, J. J. Contrasting clinical and cardiovascular risk status between early and later onset type 2 diabetes. Diab. Vasc. Dis. Res. 2, 73-75 (2005).
73. Song, S. H. and Hardisty, C. A. Early-onset type 2 diabetes mellitus: an increasing phenomenon of elevated cardiovascular risk. Expert Rev. Cardiovasc. Ther. 6, 315-322 (2008).
74. Hernandez-Alvarez, M. I. et al. Subjects with early-onset type 2 diabetes show defective activation of the skeletal muscle PGC-1a/mitofusin-2 regulatory pathway in response to physical activity. Diabetes Care 33, 645-651 (2010).
75. Burns, N. et al. Early-onset type 2 diabetes in obese white subjects is characterised by a marked defect in p cell insulin secretion, severe insulin resistance and a lack of response to aerobic exercise training. Diabetologia 50, 1500-1508 (2007).
76. Babraj, J. A. et al. Extremely short duration high intensity interval training substantially improves insulin action in young healthy males. BMC Endocr. Disord. 9, 3 (2009).
77. Frosig, C. and Richter, E. A. Improved insulin sensitivity after exercise: focus on insulin signaling. Obesity (Silver Spring) 17 (Suppl. 3), 15-20 (2009).
78. Olsen, D. B., Scheede-Bergdahl, C., Reving, D., Boushel, R. and Dela, F. The effect of rowing on endothelial function and insulin action in healthy controls and in patients with type 2 diabetes. Scand. J. Med. Sci. Sports 21, 420-430 (2011).
79. Meex, R. C. et al. Restoration of muscle mitochondrial function and metabolic flexibility in type 2 diabetes by exercise training is paralleled by increased myocellular fat storage and improved insulin sensitivity. Diabetes 59, 572-579 (2010).
80. Phielix, E., Meex, R., Moonen-Kornips, E., Hesselink, M. K. and Schrauwen, P. Exercise training increases mitochondrial content and ex vivo mitochondrial function similarly in patients with type 2 diabetes and in control individuals. Diabetologia 53, 1714-1721 (2010).
81. Thaler, J. P and Schwartz, M. W. Minireview: inflammation and obesity pathogenesis: the hypothalamus heats up. Endocrinology 151, 4109-4115 (2010).
82. Jordan, S. D., Konner, A. C. and Bruning, J. C. Sensing the fuels: glucose and lipid signaling in the CNS controlling energy homeostasis. Cell. Mol. Life Sci. 67, 3255-3273 (2010).
83. Wei, Y, Wang, D., Topczewski, F. and Pagliassotti, M. J. Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells. Am. J. Physiol. Endocrinol. Metab. 291, 275-281 (2006).
84. Eizirik, D. L., Cardozo, A. K. and Cnop, M. The role for endoplasmic reticulum stress in diabetes mellitus. Endocr. Rev. 29, 42-61 (2008).
85. Hotamisligil, G. S. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140, 900-917 (2010).
86. Ron, D. and Walter, P Signal integration in the endoplasmic reticulum unfolded protein response. Nat. Rev. Mol. Cell Biol. 8, 519-529 (2007).
87. Ozcan, U. et al. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 313, 1137-1140 (2006).
88. Ceylan-Isik, A. F., Sreejayan, N. and Ren, J. Endoplasmic reticulum chaperon tauroursodeoxycholic acid alleviates obesity- induced myocardial contractile dysfunction. J. Mol. Cell Cardiol. 50, 107-116 (2011).
89. Kars, M. et al. Tauroursodeoxycholic acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women. Diabetes 59, 1899-1905 (2010).
90. Li, J., Wang, J. J. and Zhang, S. X. Preconditioning with endoplasmic reticulum stress mitigates retinal endothelial inflammation via activation of X-box binding protein 1. J. Biol. Chem. 286, 4912-4921 (2011).
91. Harama, D. et al. A subcytotoxic dose of subtilase cytotoxin prevents lipopolysaccharide- induced inflammatory responses, depending on its capacity to induce the unfolded protein response. J. Immunol. 183, 1368-1374 (2009).
92. Ozcan, U. et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306, 457-61 (2004).
93. Nakatani, Y et al. Involvement of endoplasmic reticulum stress in insulin resistance and diabetes. J. Biol. Chem. 280, 847-851 (2005).
94. Kammoun, H. L. et al. GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice. J. Clin. Invest. 119, 1201-1215 (2009).
95. Ye, R. et al. Grp78 heterozygosity promotes adaptive unfolded protein response and attenuates diet-induced obesity and insulin resistance. Diabetes 59, 6-16 (2010).
96. Latreille, M., Laberge, M. K., Bourret, G., Yamani, L. and Larose, L. Deletion of Nck1 attenuates hepatic ER stress signaling, improves glucose tolerance and insulin signaling in liver of obese mice. Am. J. Physiol. Endocrinol. Metab. 300, E423-E434 (2011).
97. Wu, J. et al. The unfolded protein response mediates adaptation to exercise in skeletal muscle through a PGC-1a/ATF6a complex. Cell. Metab. 13, 160-169 (2011).
98. Salminen, A. and Kaarniranta, K. ER stress and hormetic regulation of the aging process. Ageing Res. Rev. 9, 211-217 (2010).
99. Huang, C. J. et al. High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated 3-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes. Diabetes 56, 2016-2027 (2007).
100. Matveyenko, A. V., Gurlo, T., Daval, M., Butler, A. E. and Butler, P. C. Successful versus failed adaptation to high-fat diet-induced insulin resistance: the role of IAPP-induced 3-cell endoplasmic reticulum stress. Diabetes 58, 906-916 (2009).
101. Bellmann, K., Jaattela, M., Wissing, D., Burkart, V. and Kolb, H. Heat shock protein hsp70 overexpression confers resistance against nitric oxide. FEBS Lett. 391, 185-188 (1996).
102. Bellmann, K., Hui, L., Radons, J., Burkart, V. and Kolb, H. Low stress response enhances vulnerability of islet cells in diabetes-prone BB rats. Diabetes 46, 232-236 (1997).
103. Margulis, B. A., Sandler, S., Eizirik, D. L., Welsh, N. and Welsh, M. Liposomal delivery of purified heat shock protein hsp70 into rat pancreatic islets as protection against interleukin 13-induced impaired 3-cell function. Diabetes 40, 1418-1422 (1991).
104. Pirot, P, Eizirik, D. L. and Cardozo, A. K. Interferon-y potentiates endoplasmic reticulum stress- induced death by reducing pancreatic 3 cell defence mechanisms. Diabetologia 49, 1229-1236 (2006).
105. Cunha, D. A. et al. Initiation and execution of lipotoxic ER stress in pancreatic 3-cells. J. Cell Sci. 121, 2308-2318 (2008).
106. Pirot, P. et al. Global profiling of genes modified by endoplasmic reticulum stress in pancreatic 3 cells reveals the early degradation of insulin mRNAs. Diabetologia 50, 1006-1014 (2007).
107. Rutkowski, D. T. et al. Adaptation to ER stress is mediated by differential stabilities of pro-survival and pro-apoptotic mRNAs and proteins. PLoS Biol. 4, e374 (2006).
108. Eizirik, D. L. and Cnop, M. ER stress in pancreatic 3 cells: the thin red line between adaptation and failure. Sci.Signal. 3, pe7 (2010).
109. Hung, C. C., Ichimura, T., Stevens, J. L. and Bonventre, J. V. Protection of renal epithelial cells against oxidative injury by endoplasmic reticulum stress preconditioning is mediated by ERK1/2 activation. J. Biol. Chem. 278, 29317-29326 (2003).
110. Cunha, D. A. et al. Glucagon-like peptide-1 agonists protect pancreatic 3-cells from lipotoxic endoplasmic reticulum stress through upregulation of BiP and JunB. Diabetes 58, 2851-2862 (2009).
111. Yusta, B. et al. GLP-1 receptor activation improves 3 cell function and survival following induction of endoplasmic reticulum stress. Cell. Metab. 4, 391-06 (2006).
112. Johnson, J. D. et al. Different effects of FK506, rapamycin, and mycophenolate mofetil on glucose-stimulated insulin release and apoptosis in human islets. Cell Transplant. 18, 833-845 (2009).
113. Vilsboll, T. The effects of glucagon-like peptide-1 on the 3 cell. Diab. Obes. Metab. 11 (Suppl. 3), 11-18 (2009).
114. Ruderman, N. B. et al. AMPK and SIRT1: a long¬standing partnership? Am. J. Physiol. Endocrinol. Metab. 298, 751-760 (2010).
115. Gillum, M. P., Erion, D. M. and Shulman, G. I. Sirtuin-1 regulation of mammalian metabolism. Trends Mol. Med. 17, 8-13 (2010).
116. Vetterli, L., Brun, T., Giovannoni, L., Bosco, D. and Maechler, P. Resveratrol potentiates glucose- stimulated insulin secretion in INS-1E 3-cells and human islets through a SIRT1-dependent mechanism. J. Biol. Chem. 286, 6049-6060 (2011).
117. Ling, Z., Van de Casteele, M., Eizirik, D. L. and Pipeleers, D. G. Interleukin-13-induced alteration in a 3-cell phenotype can reduce cellular sensitivity to conditions that cause necrosis but not to cytokine-induced apoptosis. Diabetes 49, 340-345 (2000).
118. Halban, P. A., German, M. S., Kahn, S. E. and Weir, G. C. Current status of islet cell replacement and regeneration therapy. J. Clin. Endocrinol. Metab. 95, 1034-1043 (2010).
119. Gianani, R. 3 cell regeneration in human pancreas. Semin. Immunopathol. 33, 23-27 (2011).
120. Eberhard, D., Kragl, M. and Lammert, E. ‘Giving and taking’: endothelial and 3-cells in the islets of Langerhans. Trends Endocrinol. Metab. 21, 457-63 (2010).
121. De Silva, N. M. and Frayling, T. M. Novel biological insights emerging from genetic studies of type 2 diabetes and related metabolic traits. Curr. Opin. Lipidol. 21, 44-50 (2010).
122. Smushkin, G. and Vella, A. Genetics of type 2 diabetes. Curr. Opin. Clin. Nutr. Metab. Care 13, 471-77 (2010).
123. Korsgren, O., Jansson, L., Sandler, S., and Andersson, A. Hyperglycemia-induced 3 cell toxicity. The fate of pancreatic islets transplanted into diabetic mice is dependent on their genetic background. J. Clin. Invest. 86, 2161-2168 (1990).
124. Peeters, A. V. et al. Association of SIRT1 gene variation with visceral obesity. Hum. Genet. 124, 431-36 (2008).
125. van den Berg, S. W. et al. Genetic variations in regulatory pathways of fatty acid and glucose metabolism are associated with obesity phenotypes: a population-based cohort study. Int. J. Obes. (Lond.) 33, 1143-1152 (2009).
126. Zillikens, M. C. et al. SIRT1 genetic variation is related to BMI and risk of obesity. Diabetes 58, 2828-2834 (2009).
127. Weyrich, P. et al. SIRT1 genetic variants associate with the metabolic response of Caucasians to a controlled lifestyle intervention—the TULIP Study. BMC Med. Genet. 9, 100 (2008).
128. Gouda, H. N. et al. The association between the peroxisome proliferator-activated receptor- gamma2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: a HuGE review and meta-analysis. Am. J. Epidemiol. 171, 645-655 (2010).
129. Bao, W. et al. Association between heme oxygenase-1 gene promoter polymorphisms and type 2 diabetes mellitus: a HuGE review and meta-analysis. Am. J. Epidemiol. 172, 631-636 (2010).
130. Pearson, K. J. et al. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell. Metab. 8, 157-168 (2008).
131. Hardie, D. G. Sensing of energy and nutrients by AMP-activated protein kinase. Am. J. Clin. Nutr. 93, 891-896 (2011).